Background: Reducing symptoms of depression is an important target in the treatment of borderline personality disorder (BPD). Although current treatments for BPD are effective in reducing depression, the average post-treatment level of depression remains high.
Strong evidence suggests that depression is a common experience among individuals meeting criteria for borderline personality disorder (BPD). For example, in carefully controlled studies, comorbidity rates between BPD and current mood disorder range between 31 and 61% for major depressive disorder (MDD) and between 12 and 24% for dysthymia (Comtois, Cowley, Dunner, & Roy-Byrne, 1999; Skodol et al., 1999; Zimmerman & Mattia, 1999) . Moreover, up to 83% of individuals suffering from BPD report a history of MDD, up to 39% report a history of dysthymia (Zanarini et al., 1998) , and 37% meet criteria for depressive personality disorder (Grilo, Sanislow, & McGlashan, 2002) . Additionally, individuals meeting criteria for both BPD and MDD exhibit greater severity of depression in self-reports than individuals with MDD but without BPD (e.g., Abela, Payne, & Moussaly, 2006; Stanley & Wilson, 2006) . Finally, individuals with BPD often suffer from depressive symptoms even when they do not meet full criteria for any affective disorder. For example, chronic dysphoric mood states, negative self-evaluations, and feelings of hopelessness and helplessness are commonly found in individuals suffering from BPD (Gunderson & Phillips, 1991; Hooley, 2007; Trull, 2001; Zittel-Conklin & Westen, 2005) . These findings imply that reducing the suffering associated with depressive symptoms is an important way of reducing the suffering of BPD individuals.
Fortunately, the results of major outcome-studies of the past decade indicate that today's treatments for BPD are effective in reducing depression (Bateman & Fonagy, 1999; Bohus et al., 2004 Bohus et al., , 2000 Brown, Newman, Charlesworth, Crits-Christoph, & Beck, 2004; Koons et al., 2001; Krö ger et al., 2006; Linehan et al., 2006; Turner, 2000) . Pre-post effect sizes (Cohen's d) in these studies range from 0.54 to 2.1 (Mdn ¼ 1.1) for the Beck Depression Inventory (BDI), and from 0.17 to 2.55 (Mdn ¼ 0.93) for the Hamilton Rating Scale for Depression (HRSD). However, these studies also demonstrate a significant post-treatment level of depression, with mean values ranging between M ¼ 13.4-25.1 for the BDI (Mdn ¼ 20.9) and M ¼ 7.5-19.1 for the HRSD (Mdn ¼ 14.0). In fact, most of these studies report post-treatment mean depression scores corresponding to moderate or even severe levels of depression. Thus, even after carefully conducted state-of-the-art BPD-treatments, a great amount of depression-related suffering remains in these patients. Considering that residual symptoms of depression are known to be important predictors of relapse after treatment for unipolar depression (Judd et al., 1998) and that residual depressive symptoms are likely to trigger more typical symptoms of BPD (which have been conceptualized as dysfunctional attempts to avoid aversive inner experiences; Linehan, 1993a), it can be concluded that there is a considerable need to identify factors impeding the reduction of depression during treatment for BPD.
Evidence-based maintaining factors for depression include: a depressogenic attributional style (Abramson, Metalsky, & Alloy, 1989) , hopelessness (Beck, Weissman, Lester, & Trexler, 1974) , low self-esteem (Brown & Harris, 1978) , dysfunctional attitudes (Beck, 1967) and rumination (Nolen-Hoeksema, 1991) . All these factors are significantly associated with BPD (Abela et al., 2006) . Another concept that is currently discussed as a putative risk-factor for the development and maintenance of depression is the general tendency to react towards aversive experiences with avoidanceoriented response patterns (e.g., Hayes, Beevers, Feldman, Laurenceau, & Perlman, 2005; Ottenbreit & Dobson, 2004) . These response tendencies are thought to lead to: loss of reinforcement (Ferster, 1973; Jacobson, Martell, & Dimidjian, 2001) Hayes, Wilson, Gifford, Follette, and Strosahl (1996) have proposed the term of experiential avoidance (EA) to summarize a broad range of potentially problematic behaviors that individuals apply in order to avoid aversive experiences. According to Hayes et al. (2004, p. 554) , EA is ''a phenomenon that occurs when a person is unwilling to remain in contact with particular private experiences (e.g., bodily sensations, emotions, thoughts, memories, images, behavioral predispositions) and takes steps to alter the form or frequency of these experiences or the contexts that occasion them, even when these forms of avoidance cause behavioral harm.'' In order to measure EA, Hayes et al. (2004) developed the Acceptance and Actions Questionnaire (AAQ), a self-report measure that assesses constructs considered as important indicators of EA. The total score of the AAQ has been demonstrated to be strongly associated with self-report measures of depression (for a review see Hayes, Luoma, Bond, Masuda, & Lillis, 2006). Moreover, two longitudinal studies in non-clinical samples provide further preliminary support for the assumed causal effect of EA on depression (Bond & Bunce, 2003; Kashdan, Barrios, Forsyth, & Steger, 2006) . However, due to the striking lack of more rigorous tests of causal effects in clinical populations, it is unclear whether EA is a cause or merely a consequence of depression.
Several findings suggest that EA might be particularly important for the maintenance of depression in BPD: first, BPD individuals report more frequently avoidance-oriented response patterns in coping inventories (Bijttebier & Vertommen, 1999; Kruedelbach, McCormick, Schulz, & Gruenreich, 1993; Vollrath, Alnaes, & Torgersen, 1998) , 2005) . Third, the tendency to suppress negative thoughts was shown to moderate the effect of negative affect on borderline characteristics (Rosenthal, Cheavens, Lejuez, & Lynch, 2005) . However, at this point no study has explicitly investigated the association between EA and depression in individuals treated for BPD.
Given that a) the reduction of depression is an important target in the treatment for BPD, b) there is a need to improve the effects of BPD treatments on depression, and c) EA has repeatedly been demonstrated to be associated both with depression and BPD, the aim of this study is to clarify whether EA impedes the reduction of depression during treatment for BPD by testing the following hypotheses:
1. EA is significantly associated with higher levels of depression before, during and after treatment for BPD. 2. The reduction of EA during treatment for BPD is significantly associated with a greater reduction of depression. 3. The level of EA predicts subsequent reduction of depression during treatment for BPD, whereas the level of depression does not predict subsequent changes in EA.
Methods

Participants
Levels of EA and depression were assessed in 81 female outpatients during 1 year of treatment for BPD. Assessment took place at baseline and at 4-month intervals during the treatment. All subjects were participants in a randomized controlled trial in which dialectical behavioral therapy (DBT; Linehan, 1993a Linehan, , 1993b ) was compared to treatment by community experts (TBE; Linehan et al., 2006) . Of the 101 participants in the intent-to-treat sample of this study, the current study included the 81 individuals who completed the Acceptance and Action Questionnaire at least once during the first year of treatment 1 . Participants were diagnosed with BPD based on both the International Personality Disorders Examination (IPDE; Loranger, 1995) and the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II; First, Spitzer, Gibbons, Williams, & Benjamin, 1996) . Participants were enrolled if they had a recent and chronic history of non-suicidal self-injury or suicide attempts (i.e. two or more episodes in the previous 5 years, with one episode occurring in the previous 8 weeks). All participants gave informed consent prior to participation in the studies, and all procedures were approved by the University of Washington review board. Participants were between 18 and 44 years of age (M ¼ 28.90, SD ¼ 7.47); 75.6% earned below $15,000 per year; 40.7% had some college education; 14.8% were college graduates. The majority of the sample (86.4%) was Caucasian; 61.7% had never been married, and 14.8% were currently married. Most participants (95%) qualified for other Axis I disorders: approximately 50% had two or three other Axis I diagnoses, with the most common being anxiety disorders (80.3%), major depressive disorder (77.8%) and substance abuse disorder (25.9%); about one third (32.8%) were diagnosed with an Axis II disorder other than BPD. Participants had between 0 and 151 lifetime suicide attempts (Mdn ¼ 3, Q 1 ¼ 1, Q 3 ¼ 7) and between 2 and 301 lifetime episodes of self-injury (Mdn ¼ 26, Q 1 ¼ 11; Q 3 ¼ 68). All participants in the study received psychotherapeutic treatment for BPD. About (36, 27, 23, and 13 of the N ¼ 101 intent-to-treat sample at t1, t2, t3, and t4, respectively) were due to the AAQ not being part of the assessment battery.
